24hr Tracked Cold Chain Shipping•Free Shipping on Orders £120+•

Research peptide

ARA-290 16mg

£42.00

In stock

In stock

Earn 42 points when you buy this product
Next dispatch
  --:--:--
Dispatch cut-offs (UK time): Mon–Fri 3pm · Sat 1pm
UK delivery £4.80 · Royal Mail 24hr Tracked
Free delivery on orders over £120.00
Loyalty rewards
Earn 42 points with this product
100 points = £1 off. Join free · How it works
Affiliate programme
Earn 5% commission on every sale you refer

Tracked cold-chain shipping
Same Day Dispatch on orders before 3pm Mon–Fri, 1pm Saturday

3rd-party COAs
Published for every batch

Responsive support
Mon–Fri 9:00–17:00

Secure checkout
Encrypted payment

SKURA16

For laboratory research use only. Not for human or veterinary use.

Description

ARA-290 16 mg — Opti-Gen Peptides
For laboratory research use only.
Not for human use. Not for veterinary use.
Not licensed by the MHRA. Not a medicinal product.

Research-grade synthetic peptide supplied as a 16 mg sealed vial for lawful laboratory research in the UK. Not a food, supplement or medical device on this page. Not for diagnostic or therapeutic use. Must not be administered to people or animals.

Identification

Product name ARA-290
Also listed as ARA-290; Cibinetide; pyroglutamate helix-B surface peptide (pHBSP)
Supplier Opti-Gen Peptides
Contents 16 mg per vial
Sequence (commonly cited) pGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser
CAS 1208243-50-8
Class Synthetic EPO helix-B fragment
Intended use Laboratory / in-vitro research only

Not erythropoietin. Not darbepoetin. Not a licensed cibinetide medicine.

Quality / storage

Only the lot COA applies. Store as a laboratory chemical under institutional SOP. No preparation or application instructions on this page.

Published research context (not product claims)

ARA-290 / cibinetide was developed from work associated with Brines, Cerami and colleagues on a short peptide modelled on the helix-B surface of EPO. Papers describe it as a ligand at the innate repair receptor (EPOR–β common chain heteromer) in cell and animal models.

Separate clinical-development literature exists for cibinetide in investigational programmes. Those studies are not a UK marketing authorisation and must not be rewritten as neuropathy, pain or tissue-repair claims for this vial.

EPO haematopoietic papers must not be copied onto this fragment.

There is no MHRA marketing authorisation for this listing.

UK notice

18+. Buyer confirms lawful laboratory research use only and will not use or resell for unauthorised human or animal use.

Reviews

There are no reviews yet.

Be the first to review “ARA-290 16mg”

Your email address will not be published. Required fields are marked *

0